Amendments to Decision 2010/712/EU
Article 8
Decision 2010/712/EU is amended as follows: 1. Article 1 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 4 600 000 for Spain; (ii) EUR 3 000 000 for Italy; (iii) EUR 90 000 for Cyprus; (iv) EUR 1 040 000 for Portugal; (v) EUR 1 350 000 for the United Kingdom.’; (c) in paragraph 3, points (a) to (d) are replaced by the following: ‘(a) for a rose bengal test : EUR 0,24 per test; (b) for a SAT test : EUR 0,24 per test; (c) for a complement fixation test : EUR 0,48 per test; (d) for an ELISA test : EUR 1,2 per test’; 2. Article 2 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 16 000 000 for Ireland; (ii) EUR 18 500 000 for Spain; (iii) EUR 5 500 000 for Italy; (iv) EUR 1 440 000 for Portugal; (v) EUR 26 500 000 for the United Kingdom.’; (c) in paragraph 3, points (a) and (b) are replaced by the following: ‘(a) for a tuberculin test : EUR 2,4 per test; (b) for a gamma-interferon test : EUR 6 per test’; 3. Article 3 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 160 000 for Greece; (ii) EUR 9 200 000 for Spain; (iii) EUR 4 200 000 for Italy; (iv) EUR 85 000 for Cyprus; (v) EUR 2 260 000 for Portugal.’; (c) in paragraph 3, points (a) and (b) are replaced by the following: ‘(a) for a rose bengal test : EUR 0,24 per test; (b) for a complement fixation test : EUR 0,48 per test;’; 4. Article 4 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 420 000 for Belgium; (ii) EUR 10 000 for Bulgaria; (iii) EUR 1 700 000 for the Czech Republic; (iv) EUR 0 for Denmark; (v) EUR 400 000 for Germany; (vi) EUR 10 000 for Estonia; (vii) EUR 10 000 for Ireland; (viii) EUR 100 000 for Greece; (ix) EUR 5 200 000 for Spain; (x) EUR 3 000 000 for France; (xi) EUR 300 000 for Italy; (xii) EUR 20 000 for Latvia; (xiii) EUR 5 000 for Lithuania; (xiv) EUR 60 000 for Hungary; (xv) EUR 10 000 for Malta; (xvi) EUR 50 000 for the Netherlands; (xvii) EUR 160 000 for Austria; (xviii) EUR 50 000 for Poland; (xix) EUR 1 650 000 for Portugal; (xx) EUR 100 000 for Romania; (xxi) EUR 50 000 for Slovenia; (xxii) EUR 60 000 for Slovakia; (xxiii) EUR 20 000 for Finland; (xxiv) EUR 20 000 for Sweden.’; (c) in paragraph 3, points (a) to (f) are replaced by the following: ‘(a) for an ELISA test : EUR 3 per test; (b) for a PCR test : EUR 12 per test; (c) for the purchase of monovalent vaccines : EUR 0,36 per dose; (d) for the purchase of bivalent vaccines : EUR 0,54 per dose; (e) for the administration of vaccines to bovine animals : EUR 1,80 per bovine animal vaccinated, regardless of the number and types of doses used; (f) for the administration of vaccines to ovine or caprine animals : EUR 0,90 per ovine or caprine animal vaccinated, regardless of the number and types of doses used.’; 5. Article 5 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 1 200 000 for Belgium; (ii) EUR 25 000 for Bulgaria; (iii) EUR 2 100 000 for the Czech Republic; (iv) EUR 340 000 for Denmark; (v) EUR 1 000 000 for Germany; (vi) EUR 40 000 for Estonia; (vii) EUR 120 000 for Ireland; (viii) EUR 1 000 000 for Greece; (ix) EUR 1 300 000 for Spain; (x) EUR 660 000 for France; (xi) EUR 1 700 000 for Italy; (xii) EUR 150 000 for Cyprus; (xiii) EUR 1 650 000 for Latvia; (xiv) EUR 20 000 for Luxembourg; (xv) EUR 2 400 000 for Hungary; (xvi) EUR 150 000 for Malta; (xvii) EUR 3 900 000 for the Netherlands; (xviii) EUR 1 200 000 for Austria; (xix) EUR 4 800 000 for Poland; (xx) EUR 65 000 for Portugal; (xxi) EUR 500 000 for Romania; (xxii) EUR 120 000 for Slovenia; (xxiii) EUR 600 000 for Slovakia; (xxiv) EUR 75 000 for the United Kingdom.’; (c) in paragraph 3, points (a) to (e) are replaced by the following: ‘(a) for a bacteriological test (cultivation/isolation) : EUR 8,4 per test; (b) for the purchase of vaccine : EUR 0,06 per dose; (c) for serotyping of relevant isolates of Salmonella spp. : EUR 24 per test; (d) for a bacteriological test to verify the efficiency of disinfection of poultry houses after depopulation of a salmonella-positive flock : EUR 6 per test; (e) for a test for the detection of antimicrobials or bacterial growth inhibitory effect in tissues from birds from flocks tested for salmonella : EUR 6 per test.’; 6. Article 6 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 120 000 for Bulgaria; (ii) EUR 1 600 000 for Germany; (iii) EUR 240 000 for France; (iv) EUR 160 000 for Italy; (v) EUR 700 000 for Hungary; (vi) EUR 700 000 for Romania; (vii) EUR 30 000 for Slovenia; (viii) EUR 300 000 for Slovakia.’; (c) in paragraph 3, ‘EUR 2,5’ is replaced by ‘EUR 3’; 7. Article 8 is amended as follows: (a) in paragraph 2(b), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(c) is replaced by the following: ‘(c) shall not exceed the following: (i) EUR 90 000 for Belgium; (ii) EUR 25 000 for Bulgaria; (iii) EUR 70 000 for the Czech Republic; (iv) EUR 80 000 for Denmark; (v) EUR 300 000 for Germany; (vi) EUR 10 000 for Estonia; (vii) EUR 75 000 for Ireland; (viii) EUR 50 000 for Greece; (ix) EUR 150 000 for Spain; (x) EUR 150 000 for France; (xi) EUR 1 000 000 for Italy; (xii) EUR 20 000 for Cyprus; (xiii) EUR 45 000 for Latvia; (xiv) EUR 10 000 for Lithuania; (xv) EUR 10 000 for Luxembourg; (xvi) EUR 360 000 for Hungary (xvii) EUR 20 000 for Malta; (xviii) EUR 360 000 for the Netherlands; (xix) EUR 60 000 for Austria; (xx) EUR 100 000 for Poland; (xxi) EUR 45 000 for Portugal; (xxii) EUR 180 000 for Romania; (xxiii) EUR 50 000 for Slovenia; (xxiv) EUR 15 000 for Slovakia; (xxv) EUR 25 000 for Finland; (xxvi) EUR 50 000 for Sweden; (xxvii) EUR 160 000 for the United Kingdom.’; (c) in paragraph 3, points (a) to (e) are replaced by the following: ‘(a) ELISA test : EUR 2,4 per test; (b) agar gel immune diffusion test : EUR 1,44 per test; (c) HI test for H5/H7 : EUR 14,40 per test; (d) virus isolation test : EUR 48 per test; (e) PCR test : EUR 24 per test.’; 8. Article 9 is amended as follows: (a) in paragraph 2(c), ‘50 %’ is replaced by ‘60 %’; (b) paragraph 2(d) is replaced by the following: ‘(d) shall not exceed the following: (i) EUR 1 900 000 for Belgium; (ii) EUR 330 000 for Bulgaria; (iii) EUR 1 030 000 for the Czech Republic; (iv) EUR 1 370 000 for Denmark; (v) EUR 7 750 000 for Germany; (vi) EUR 330 000 for Estonia; (vii) EUR 4 000 000 for Ireland; (viii) EUR 2 000 000 for Greece; (ix) EUR 6 650 000 for Spain; (x) EUR 18 850 000 for France; (xi) EUR 6 000 000 for Italy; (xii) EUR 1 700 000 for Cyprus; (xiii) EUR 320 000 for Latvia; (xiv) EUR 720 000 for Lithuania; (xv) EUR 125 000 for Luxembourg; (xvi) EUR 1 180 000 for Hungary; (xvii) EUR 25 000 for Malta; (xviii) EUR 3 530 000 for the Netherlands; (xix) EUR 1 800 000 for Austria; (xx) EUR 3 440 000 for Poland; (xxi) EUR 1 800 000 for Portugal; (xxii) EUR 1 000 000 for Romania; (xxiii) EUR 250 000 for Slovenia; (xxiv) EUR 550 000 for Slovakia; (xxv) EUR 580 000 for Finland; (xxvi) EUR 850 000 for Sweden; (xxvii) EUR 6 500 000 for the United Kingdom.’; (c) in paragraph 3(d) ‘EUR 10’ is replaced by ‘EUR 12’; 9. Article 10, paragraph 2(c) is amended as follows: (a) in point (i) ‘EUR 1 800 000’ is replaced by ‘EUR 850 000’; (b) in point (ii) ‘EUR 620 000’ is replaced by ‘EUR 570 000’; (c) in point (iv) ‘EUR 7 110 000’ is replaced by ‘EUR 8 110 000’; (d) in point (v) ‘EUR 5 000 000’ is replaced by ‘EUR 2 100 000’; (e) in point (vii) ‘EUR 200 000’ is replaced by ‘EUR 290 000’; 10. in Article 10 paragraph 4, ‘paragraphs 2 and 3’ is replaced by ‘paragraph 2(a), paragraph 2(b) and paragraph 3’; 11. Article 11, paragraph 5(c) is amended as follows: (a) in point (i) ‘EUR 2 250 000’ is replaced by ‘EUR 1 600 000’; (b) in point (ii) ‘EUR 1 800 000’ is replaced by ‘EUR 1 500 000’; (c) in point (v) ‘EUR 740 000’ is replaced by ‘EUR 850 000’; 12. in Article 11 paragraph 7, ‘paragraphs 5 and 6’ is replaced by ‘paragraph 5(a), paragraph 5(b) and paragraph 6’.